HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients.
A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology
Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery.
very.

Biotechnology

Health Care

Pharmaceutical

HTL Biotechnology

François Fournier

Nathalie Chevallon

Laurent Bouillaut

Jason O'Neill

Francis B Maddalo

Marie-Armelle Floc'H

Nicolas Préfol

Laurène Brodiez

Emmanuel Lefèvre

Cyril Picault

Christophe Coyard

Bertrand Hurtault

Business Operations

Leadership Team

Product Development and Management

Research and Development

Quality Assurance and Compliance

��

Teams at HTL Biotechnology

Business Operations

Leadership Team

Product Development and Management

Research and Development

Quality Assurance and Compliance

��������

Teams at HTL Biotechnology

Business Operations

Leadership Team

Product Development and Management

Research and Development

Quality Assurance and Compliance

��